Related Experiment Video
Updated: Jun 20, 2026
09:12
Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins
Published on: January 18, 2019
Novel targets for immunotherapy in glomerulonephritis
1Department of Medicine and Research Service, Duke University Medical Center and Durham Veterans Affairs Medical Center, Durham, North Carolina, USA.
Biologics : Targets & Therapy
|August 27, 2009
Summary
Novel therapies targeting specific molecules like alpha3(IV)NC1 collagen and complement show promise for treating glomerulonephritis, a common cause of kidney disease. These targeted interventions aim to improve upon current nonspecific immunosuppression treatments.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Glomerulonephritis is a leading cause of chronic kidney disease and end-stage renal failure.
- Current treatments involve nonspecific and potentially toxic immunosuppression with variable efficacy.
- Recent advances in understanding glomerulonephritis pathogenesis offer opportunities for targeted therapies.
Purpose of the Study:
- To review the therapeutic potential of novel targets in glomerulonephritis.
- To highlight antigens and molecular pathways amenable to intervention.
- To discuss the future of individualized, disease-specific therapies for glomerulonephritis.
Main Methods:
- Review of recent scientific literature on glomerulonephritis pathogenesis.
- Identification of key antigens (alpha3(IV)NC1 collagen, podocyte neutral endopeptidase) and effector molecules (IgG Fc receptors, complement) for therapeutic targeting.
- Analysis of the potential for targeted manipulation in human glomerulonephritis.
Main Results:
- Alpha3(IV)NC1 collagen and podocyte neutral endopeptidase are identified as promising therapeutic antigens.
- IgG Fc receptors and complement pathways are highlighted as key targets for intervention.
- These targets are considered particularly amenable to therapeutic manipulation in humans.
Conclusions:
- Targeted interventions based on specific antigens and molecular pathways offer a promising alternative to current immunosuppressive therapies for glomerulonephritis.
- Further research into the diverse mechanisms of glomerulonephritis will enable the development of individualized, disease-specific treatments.
- The future of glomerulonephritis treatment lies in precision medicine approaches.
Related Concept Videos
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:29Acute Kidney Injury II: Pathophysiology
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...